ProQR Therapeutics (NASDAQ:PRQR) Coverage Initiated by Analysts at Evercore ISI
Evercore ISI initiated coverage on shares of ProQR Therapeutics (NASDAQ:PRQR – Free Report) in a research note released on Tuesday morning, Marketbeat Ratings reports. The brokerage issued an outperform rating and a $5.00 price objective on the biopharmaceutical company’s stock. PRQR has been the topic of a number of other reports. Citigroup upgraded ProQR Therapeutics […]
Evercore ISI initiated coverage on shares of ProQR Therapeutics (NASDAQ:PRQR – Free Report) in a research note released on Tuesday morning, Marketbeat Ratings reports. The brokerage issued an outperform rating and a $5.00 price objective on the biopharmaceutical company’s stock. PRQR has been the topic of a number of other reports. Citigroup upgraded ProQR Therapeutics […]
